- New
Gaiabis Maui Waui is a Swiss indoor CBD flower with a tropical profile inspired by Hawaiian sativas. Pineapple and citrus lead, softened by a lightly sweet note.
Maui Waui has a distinctly tropical aromatic profile. Pineapple leads alongside lively citrus notes, while a light sweetness rounds out the fruitier side of the flower.
Subtle pine and earthy notes appear in the background, adding a more botanical dimension without overtaking the tropical character. This progression gives the variety an aromatic identity shaped by both bright fruit and a more grounded finish.
Grown indoors in Switzerland, the flowers are small to medium in size. Their structure is tight, regular, compact and dense.
The brown-green colour is marked by numerous orange to brown pistils. A light resinous presence on the surface completes their compact appearance.
The genetic profile draws inspiration from Hawaiian sativa varieties. Here, that influence is expressed through the exotic tropical direction of Maui Waui and its combination of pineapple, citrus and gentle sweetness.
The CBD concentration is 13.3 %. The flower also contains 0.6 % THC, 0.5 % CBG and 0.5 % CBC. These values describe the main cannabinoids quantified for this reference without implying any therapeutic effect.
Store the flowers in a cool, dry place away from light to help preserve their aromatic and physical characteristics.
This product is reserved for adults. Its THC content is below 1 %, in accordance with Swiss legislation.
Data sheet
We deliver throughout Switzerland from our shop in Bulle (Fribourg). Shipments are sent by Swiss Post in discreet, trackable parcels. Delivery abroad is not possible in order to ensure the legal compliance of our products.
Delivery costs in Switzerland depend on the selected method and order amount:
Prices include VAT and are displayed in the basket before payment.
Yes. As soon as your order is shipped, you receive an email containing your Swiss Post tracking number. You can track your parcel in real time on the Swiss Post website or app. In the event of a delay or problem, our team remains available to help.
CBD is not subject to narcotics legislation. In Switzerland, hemp containing less than 1% THC does not fall under this legislation, but its sale remains subject to the rules of the relevant product category, for example those governing foodstuffs, cosmetics or tobacco products.
A THC content below 1% is therefore not, on its own, sufficient to determine whether a product can be sold or used for a given purpose.
Yes. Some of our products may contain THC, but always in quantities below 1%, in accordance with Swiss legislation. This level is too low to cause psychoactive effects. All our products are legal, tested and compliant with the applicable Swiss requirements.
CBD (cannabidiol) and THC (tetrahydrocannabinol) are two cannabis molecules.
CBD is not psychoactive: it does not produce a “high”.
THC is the substance responsible for psychotropic effects.
Our products are rich in CBD and contain little or no THC.